These results suggest that the expression status of the DDR molecules PARP1, γH2AX, BRCA1, and BRCA2 are important for the prognosis of cancer patients and support the notion that these molecules might be therapeutic targets of STS. This evidence concerns the gene PARP1 and telomere syndrome.